arrow
返回

Essential phospholipids decrease apoptosis and increase membrane transport in human hepatocyte cell lines

delete2022-09-24
delete5
delete
OA
AI
D
Dominik Wupperfeld
G
Gert Fricker
B
Béatrice Bois De Fer
L
Larissa Frank
A
Annika Wehrle
B
Branko Popović *
DOI:10.1186/s12944-022-01698-8delete
delete原文链接
delete分享
delete收藏
查看原文
摘要

摘要

En 中文
Background Essential phospholipids (EPL) have hepatoprotective effects across many liver diseases/conditions. The impact of EPL on hepatocyte function in vitro was investigated. Methods Effects of noncytotoxic concentrations of EPL (0.1 and 0.25 mg/ml), and its constituents, polyenylphosphatidylcholine (PPC) and phosphatidylinositol (PI) (both at 0.1 and 1 mg/ml), on membrane fluidity, apoptosis and extracellular transport versus controls were investigated in human hepatocyte cell lines (HepG2, HepaRG, steatotic HepaRG). Results Significantly increased membrane fluidity occurred with all 3 phospholipids (PLs) in HepG2 cultures, and with PI (1 mg/ml) in steatotic HepaRG cells. Significantly decreased tamoxifen-induced apoptosis was observed in HepG2 cells with EPL, PPC and PI. Breast cancer resistance protein (BCRP) activity was significantly increased by EPL and PI in HepG2 cells. Multidrug resistance-associated protein 2 (MRP-2) activity was unaffected by any PL in HepG2 cells, and significantly increased by EPL, PI and PPC (1 mg/ml) in HepaRG cells, and by PI (1 mg/ml) in steatotic HepaRG cells. Bile salt export protein (BSEP) activity in HepG2 cells and steatotic HepaRG cells was significantly increased by EPL (0.25 mg/ml), and PPC (both concentrations), but not by PI. The PLs had no effects on HepaRG cell BSEP activity. P-glycoprotein (P-GP) activity was significantly increased by all compounds in HepG2 cells. PI (1 mg/ml) significantly increased P-GP activity in HepaRG and steatotic HepaRG cells. Conclusions EPL, PPC, and PI increased hepatocyte membrane fluidity, decreased apoptosis and increased hepatocellular export, all of which may improve liver function. These in-vitro investigations provide valuable insights into the mechanism of action of EPL.
Keyword:
HepG2
HepaRG
Steatotic HepaRG
Nonalcoholic fatty liver disease
AI总结

AI总结

对已上传原文的论文进行重点信息的提取,主要内容包括:简要概述、研究摘要、背景介绍、关键亮点、图文解析、展望与总结。

期刊

Lipids in Health and Disease 封面图
Lipids in Health and Disease
IF:
4.2
论文数:
4.1K
被引数:
1.4W

机构

S
sanofi aventis
学者数:
1
论文数: 1
被引数: 0
R
Ruprecht-Karls University Heidelberg
学者数:
12
论文数: 5
被引数: 2
S
sanofi france
学者数:
2.0K
论文数: 1.4K
被引数: 1.6K
H
Helmholtz Association
学者数:
1.1K
论文数: 363
被引数: 9.3W
学者 查看更多机构
引用论文

引用论文

NanoSpec: a diffraction limited micro-spectrograph for pico- and nano-satellites
err2012-08-22
err0
PREAI
errChristopher H. Betters; S. G. Leon-Saval; J. Bland-Hawthorn
err分享
err收藏
err分享
err收藏
err分享
err收藏
Latin American Association for the study of the liver (ALEH) practice guidance for the diagnosis and treatment of non-alcoholic fatty liver disease拉丁美洲肝脏研究协会 (ALEH) 诊断和治疗非酒精性脂肪肝疾病的实践指南
err2020-11-01
err88
errOAAI
errPablo Arab, Juan; Dirchwolf, Melisa; Alvares-da-Silva, Mario Reis; Barrera, Francisco; Benitez, Carlos; Castellanos-Fernandez, Marlene; Castro-Narro, Graciela; Chavez-Tapia, Norberto; Chiodi, Daniela; Cotrim, Helma; Cusi, Kenneth; Marques Souza de Oliveira, Claudia Pinto; Diaz, Javier; Fassio, Eduardo; Gerona, Solange; Girala, Marcos; Hernandez, Nelia; Marciano, Sebastian; Masson, Walter; Mendez-Sanchez, Nahum; Leite, Nathalie; Lozano, Adelina; Padilla, Martin; Panduro, Arturo; Parana, Raymundo; Parise, Edison; Perez, Marlene; Poniachik, Jaime; Carlos Restrepo, Juan; Ruf, Andres; Silva, Marcelo; Tagle, Martin; Tapias, Monica; Torres, Kenia; Vilar-Gomez, Eduardo; Costa Gil, Jose Eduardo; Gadano, Adrian; Arrese, Marco
err分享
err收藏
Metalloprotease inhibitor blocks angiotensin II-induced migration through inhibition of epidermal growth factor receptor transactivation
err2002-06-01
err0
PREAI
errShuichi Saito; Gerald D Frank; Evangeline D Motley; Peter J Dempsey; Hirotoshi Utsunomiya; Tadashi Inagami; Satoru Eguchi
err分享
err收藏
Activity of essential phospholipids (EPL) from soybean in liver diseases
err2011-05-01
err81
PREAI
errGundermann, Karl-Josef; Kuenker, Ann; Kuntz, Erwin; Drozdzik, Marek
err分享
err收藏
学者 查看更多内容